venetoclax,olutasidenib,Cytarabine
rigel pharma,roche,abbvie,Forma Therapeutics
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'venetoclax', 'olutasidenib']
congress | #eha2023 | poster presents a subset analysis from a phase ii trial of olutasidenib. patients with idh1 mutated aml who were r/r to venetoclax-based regimens and received olutasidenib achieved durable remissions. #leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm